Table 3.
Control group | Observation group | ||||||
Baseline | After | P1 | Baseline | After | P1 | P2 | |
Erector spine muscle | |||||||
Healthy side | 78.44 ± 12.03 | 86.50 ± 11.25 | t = -7.55 P = .00 | 79.22 ± 12.33 | 94.39 ± 12.01 | t = -11.21 P = .00 | t = -2.09 P = .04 |
Affected side | 75.39 ± 12.27 | 85.83 ± 11.01 | t = -11.08 P = .00 | 75.39 ± 12.61 | 92.06 ± 13.44 | t = -13.77 P = .00 | t = -1.56 P = .13 |
Polyfidus muscle | |||||||
Healthy side | 84.23 ± 16.97 | 94.06 ± 9.33 | t = -26.01 P = .00 | 90.22 ± 11.71 | 103.56 ± 10.41 | t = -13.15 P = .00 | t = -2.96 P = .01 |
Affected side | 80.89 ± 8.48 | 89.28 ± 7.79 | t = -8.52 P = .00 | 84.00 ± 15.34 | 101.74 ± 12.60 | t = -21.91 P = .00 | t = -3.67 P = .01 |
The MF of affected side of the erector muscle of spine and multifidus muscles in the observation group after 4 weeks intervention was significantly higher than those before treatment both in the observation and control group (P < .05, respectively). P1 = P value compared within group, P2 = P value compared between two groups after therapy.